Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Brainstorm Cell (BCLI)

Brainstorm Cell (BCLI)
0.8899 +0.0299 (+3.48%) 12:29 ET [NASDAQ]
0.8600 x 11 0.8900 x 10
Realtime by (Cboe BZX)
0.8600 x 11 0.8900 x 10
Realtime 0.9299 +0.0699 (-) 09:07 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.8442
Day High
0.8900
Open 0.8442
Previous Close 0.8600 0.8600
Volume 14,227 14,227
Avg Vol 361,974 361,974
Stochastic %K 25.60% 25.60%
Weighted Alpha -87.73 -87.73
5-Day Change +0.0854 (+11.00%) +0.0854 (+11.00%)
52-Week Range 0.7233 - 10.0485 0.7233 - 10.0485
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,609
  • Shares Outstanding, K 6,522
  • Annual Sales, $ 0 K
  • Annual Income, $ -11,620 K
  • EBIT $ -12 M
  • EBITDA $ -11 M
  • 60-Month Beta 0.60
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.66
  • Most Recent Earnings $-0.51 on 03/31/25
  • Next Earnings Date 05/13/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 97.05%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.75
  • Growth Rate Est. (year over year) +133,300.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7233 +19.11%
on 04/16/25
Period Open: 1.4100
1.5900 -45.82%
on 03/26/25
-0.5485 (-38.90%)
since 03/21/25
3-Month
0.7233 +19.11%
on 04/16/25
Period Open: 2.1300
2.2700 -62.05%
on 01/24/25
-1.2685 (-59.55%)
since 01/22/25
52-Week
0.7233 +19.11%
on 04/16/25
Period Open: 8.1015
10.0485 -91.43%
on 05/22/24
-7.2400 (-89.37%)
since 04/22/24

Most Recent Stories

More News
News Movers: Yesterday’s Hottest News That Could Move the Needle Today

Your Only Digest of Market-Moving News and Rumours From High-Growth, Small Cap Stocks

BCLI : 0.8899 (+3.48%)
LASE : 2.76 (+8.66%)
PPBT : 2.80 (-1.41%)
BCTX : 5.14 (+22.67%)
STXS : 1.9700 (+8.24%)
DMGGF : 0.1810 (+7.10%)
News Movers: Today’s Hottest News That Could Move the Needle Tomorrow

WealthyVC.com scans North America’s 10,000+ publicly listed stocks across all seven exchanges to find the market-moving news that matters. Our focus is on quality, liquid, growth-oriented companies in...

BCLI : 0.8899 (+3.48%)
LASE : 2.76 (+8.66%)
PPBT : 2.80 (-1.41%)
BCTX : 5.14 (+22.67%)
STXS : 1.9700 (+8.24%)
DCTH : 11.66 (+2.82%)
DMGGF : 0.1810 (+7.10%)
BCLI Update - Progress Supports Our 10x Plus Value Range Potential

/CNW/ -- NASDAQ: BCLI READ ACF EQUITY RESEARCH'S UPDATE NOTE HERE READ ACF EQUITY RESEARCH'S RELATED THEMATIC RESEARCH NOTE ON REGENERATIVE MEDICINE –...

BCLI : 0.8899 (+3.48%)
BCLI: Initiation - Potential 10x Return on Successful Phase 3b. Promising Post Hoc and Biomarker Analysis Underpins Our NurOwn® Clinical Effectiveness Expectation

/CNW/ -- INITIATION NOTE: BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI) is focused on developing autologous mesenchymal stem cell (MSC) therapies for the...

BCLI : 0.8899 (+3.48%)
BrainStorm Cell Therapeutics to Meet with US FDA to Discuss Development Plan for NurOwn as a Treatment of ALS

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...

BCLI : 0.8899 (+3.48%)
ROSEN, A TOP RANKED LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation - BCLI

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of...

BCLI : 0.8899 (+3.48%)
BCLI LOSS ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation - BCLI

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of...

BCLI : 0.8899 (+3.48%)
BrainStorm Cell Therapeutics Provides Update on FDA Advisory Committee Meeting to Review NurOwn for the Treatment of ALS

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...

BCLI : 0.8899 (+3.48%)
BrainStorm Cell Therapeutics Stock Trading Halted Today

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...

BCLI : 0.8899 (+3.48%)
BrainStorm Cell Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...

BCLI : 0.8899 (+3.48%)

Business Summary

BrainStorm Cell Therapeutics Inc. is a biotechnology company. It develops autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Multiple Sclerosis and Parkinson's disease. Brainstorm Cell Therapeutics is based in New York.

See More

Key Turning Points

3rd Resistance Point 0.9633
2nd Resistance Point 0.9387
1st Resistance Point 0.8993
Last Price 0.8899
1st Support Level 0.8353
2nd Support Level 0.8107
3rd Support Level 0.7713

See More

52-Week High 10.0485
Fibonacci 61.8% 6.4863
Fibonacci 50% 5.3859
Fibonacci 38.2% 4.2855
Last Price 0.8899
52-Week Low 0.7233

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro